Coherus Oncology Inc — 貸借対照表 (NASDAQ:CHRS) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 841.65 M679.33 M480.85 M629.6 M448.53 M258.34 M 負債合計 560.67 M581.61 M618.26 M823.03 M580.52 M197.33 M 純資産合計 280.97 M97.73 M-137.42 M-193.43 M-131.99 M61.01 M 負債および純資産合計 841.65 M679.33 M480.85 M629.6 M448.53 M258.34 M 有利子負債合計 377.95 M381.9 M226.77 M227.61 M228.23 M— 純負債 -163.25 M-35.29 M35.09 M109.86 M102.24 M—

ニュース

Coherus Oncology: Setting Up For Important Readouts In Mid-2026 (NASDAQ:CHRS)

Coherus Oncology (CHRS) Reports Q1 Loss, Lags Revenue Estimates

Are Medical Stocks Lagging AnaptysBio (ANAB) This Year?

Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year?

Is Biodesix (BDSX) Stock Outpacing Its Medical Peers This Year?

コヒーラス・バイオサイエンシズ、戦略的な腫瘍学へのシフトを発表

Coherus BioSciences at The Citizens Conference: Strategic Oncology Shift

Oppenheimer reiterates Coherus Biosciences stock rating at Outperform

Coherus Oncology, Inc. (CHRS) Q4 2025 Earnings Call Transcript

Coherus Oncology (CHRS) Reports Q4 Loss, Misses Revenue Estimates

【決算速報】コヒーラス・バイオサイエンシズ、売上高は予想を下回り、利益は予想と一致する結果に

Coherus BioSciences earnings matched, revenue fell short of estimates